Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year

The vaccine's efficacy rate, the highest of any candidate in late-stage clinical trials so far, was welcomed by experts who had already said that interim results showing Pfizer's shot was over 90 per cent effective were very encouraging.